Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Biweekly Cabazitaxel in Patients 65 Years or Older with mCRPC for...

Ogkologos - 7 Νοεμβρίου, 2023

Targeted Therapy for Claudin-18.2 and Combined PD-1 and TIGIT Immunotherapy for...

Ogkologos - 6 Νοεμβρίου, 2023

Perioperative Durvalumab Plus Neoadjuvant Chemotherapy Results in Greater EFS and pCR...

Ogkologos - 6 Νοεμβρίου, 2023

A Better Biomarker for Cancer Immunotherapy?

Ogkologos - 3 Νοεμβρίου, 2023

Erdafitinib Prolongs Survival in Patients with Metastatic Urothelial Carcinoma and FGFR...

Ogkologos - 3 Νοεμβρίου, 2023

7 Steps for Developing Microhabits During Cancer That Can Improve Your...

Ogkologos - 2 Νοεμβρίου, 2023

FDA Authorizes Blood Test for Assessing Risk of Hereditary Cancers

Ogkologos - 2 Νοεμβρίου, 2023

EMA Recommends Extending Indications for Zanubrutinib to Include Treatment of Patients...

Ogkologos - 2 Νοεμβρίου, 2023

4 Ways to Avoid Comparing Yourself to Others on Social Media...

Ogkologos - 31 Οκτωβρίου, 2023

Tarlatamab Shows Promise in Patients with Previously Treated Small-Cell Lung Cancer

Ogkologos - 31 Οκτωβρίου, 2023

1...104105106...440 Σελίδα 105 από 440

MOST POPULAR

Three Brothers Under The Age Of 6 Are All Fighting The...

7 Φεβρουαρίου, 2020

Remodeled CAR T-Cell Therapy Reduces Side Effects in First Clinical Trial

20 Φεβρουαρίου, 2020

EMA Recommends Granting a Marketing Authorisation for Ripretinib for the Treatment...

5 Οκτωβρίου, 2021

The Cancer Moonshot: A Midpoint Progress Update

11 Ιανουαρίου, 2021

Φόρτωση περισσοτέρων

Biweekly Cabazitaxel in Patients 65 Years or Older with mCRPC for...

Targeted Therapy for Claudin-18.2 and Combined PD-1 and TIGIT Immunotherapy for...

Perioperative Durvalumab Plus Neoadjuvant Chemotherapy Results in Greater EFS and pCR...

A Better Biomarker for Cancer Immunotherapy?

Erdafitinib Prolongs Survival in Patients with Metastatic Urothelial Carcinoma and FGFR...

7 Steps for Developing Microhabits During Cancer That Can Improve Your...

FDA Authorizes Blood Test for Assessing Risk of Hereditary Cancers

EMA Recommends Extending Indications for Zanubrutinib to Include Treatment of Patients...

4 Ways to Avoid Comparing Yourself to Others on Social Media...

Tarlatamab Shows Promise in Patients with Previously Treated Small-Cell Lung Cancer

MOST POPULAR

Three Brothers Under The Age Of 6 Are All Fighting The...

Remodeled CAR T-Cell Therapy Reduces Side Effects in First Clinical Trial

EMA Recommends Granting a Marketing Authorisation for Ripretinib for the Treatment...

The Cancer Moonshot: A Midpoint Progress Update

HOT NEWS

Immunotherapy treatment fast tracked to treat lung cancer patients in England

Do as I say, not as I do – when the...

Spring Budget 2023: What does it mean for the mission to...

Consistent Efficacy Benefit with Trastuzumab Deruxtecan versus Trastuzumab Emtansine in Patients...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ